Zylox-Tonbridge Medical Technology Co., Ltd. Class H ( (HK:2190) ) has shared an update.
Zylox-Tonbridge Medical Technology Co., Ltd. has announced a final cash dividend of RMB 0.1 per share for the financial year ending December 31, 2024. This announcement reflects the company’s financial health and commitment to providing value to its shareholders, with the payment date set for June 27, 2025, following shareholder approval on May 30, 2025.
More about Zylox-Tonbridge Medical Technology Co., Ltd. Class H
Zylox-Tonbridge Medical Technology Co., Ltd. operates in the medical technology industry, focusing on the development and provision of advanced medical devices. The company is known for its innovative solutions in the healthcare sector, aiming to enhance patient care and treatment outcomes.
YTD Price Performance: 63.08%
Average Trading Volume: 141
Technical Sentiment Signal: Sell
Current Market Cap: €717.7M
For detailed information about 2190 stock, go to TipRanks’ Stock Analysis page.